{
  "docId": "019de076-5473-7242-b1c4-ab6acd3f6564",
  "docSlug": "198a0f3704f292567efe1a435af44ee8",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 36,
  "pageCount": 39,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The chart compares the combined market size of major CPIs ($42B) against Libtayo ($0.5B) to illustrate the growth potential.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-5473-7242-b1c4-ab6acd3f6564/36",
  "deckHref": "/decks/019de076-5473-7242-b1c4-ab6acd3f6564",
  "deckJsonHref": "/decks/019de076-5473-7242-b1c4-ab6acd3f6564.json",
  "deckAnchorHref": "/decks/019de076-5473-7242-b1c4-ab6acd3f6564#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.5,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Market size comparison of CPIs vs Libtayo",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df5b835d-8836-46a0-9289-996cd3c0ba19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.45,
        "y": 0.75
      },
      "kind": "image",
      "text": "Keytruda, Opdivo, Tecentriq, Imfinzi, Libtayo logos",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e532467d-fdea-40b8-a9a7-5ea84206aa87",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.03,
        "y": 0.75
      },
      "kind": "list",
      "text": "Profile similar to Keytruda; Libtayo is entrant #5 in CPIs; Needs superior efficacy to Keytruda; Sequential combination with THIO is key",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22deab8b-6ba3-4f4d-aa23-bf6d23b88d87",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "list",
      "text": "NSCLC #1 WW Mortality: 1.7M Sales: $34B; CRC #2 WW Mortality: 1.0M Sales: $20B",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62246c0b-d3ca-490f-9b66-7e45fa9bd107",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.03,
        "y": 0.45
      },
      "kind": "list",
      "text": "5 CPIs approved for NSCLC sold $12B; >30% of NSCLC drug sales; >40% of total CPI sales; Keytruda: $7.5B in NSCLC of $21B total",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "acb30fd4-2ba7-4983-bbf2-9b9740500b67",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Developing agents for the top tumor types markets globally",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34283f4f-2973-4faa-8031-161813b5e804",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "SIGNIFICANT MARKET OPPORTUNITY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "68ffa8b0-76dd-462a-912c-e7bed97e863c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 37,
      "from": 36,
      "name": "Pareto Focus",
      "slug": "50-pareto-focus",
      "bestFor": "Resource allocation, problem prioritization, efficiency improvements",
      "matchId": "c2dc8ca8-68e3-4d6b-85b0-e788abef1965",
      "evidence": "The document presents an overview of the market opportunity and comparable companies, highlighting the key areas of focus for investors.",
      "position": 2,
      "objective": "What are the key areas of focus for MAIA Biotechnology's investment opportunity?",
      "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation",
      "confidence": 0.6,
      "description": "Show that 80% of results come from 20% of causes to drive prioritization"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}